Gunderson Dettmer advised Natera, Inc. in a follow-on public offering of 5,175,000 shares at the price to the public of $20.00 per share for a total...
You must be a Standard 1 Year member to access this content.
Patterson Belknap Webb & Tyler LLP successully advised Janssen Pharms on the Risperdal Gynecomastia Case On a motion for summary judgment, our lawyers successfully argued that...
You must be a Standard 1 Year member to access this content.
Goodwin advised Neon Therapeutics on the deal Neon Therapeutics (“NTGN”), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, closed its public offering of 6,250,000 shares of common...
You must be a Standard 1 Year member to access this content.
Goodwin advised Eidos Therapeutics on the transaction Eidos Therapeutics (“EIDX”), a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented NexPhase Capital, LP (NexPhase) in its equity stake investment in Brandt Information Services, LLC (Brandt). NexPhase is an independent private equity firm making...
You must be a Standard 1 Year member to access this content.
Goodwin advised Aerpio Pharmaceuticals, Inc. on its $45.0 million public offering of common stock and uplisting to the Nasdaq Capital Market. The company’s common stock began...
You must be a Standard 1 Year member to access this content.
Sheppard Mullin Represents Arlington Capital’s Portfolio Company, Zemax, in the sale has acquired Zemax Software Holdings, LLC., a leading global provider of optical and illumination design...
You must be a Standard 1 Year member to access this content.
Goodwin advised Toast on the transaction Toast closed a $115 million Series D funding round that values the company at $1.4 billion. The financing round was...
You must be a Standard 1 Year member to access this content.
Goodwin represented Akero Therapeutics, Inc., which announced today the completion of a $65 million Series A financing. The financing will be used to advance Akero’s lead...
You must be a Standard 1 Year member to access this content.
Choate advised Foundation Medicine in settling a Patent Infringement Lawsuit with Guardant Health Foundation Medicine, Inc. (NASDAQ:FMI) and Guardant Health, Inc. announced an agreement to settle...
You must be a Standard 1 Year member to access this content.
Goodwin advised Xeris Pharmaceuticals on the deal Xeris Pharmaceuticals (“XERS”), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and...
You must be a Standard 1 Year member to access this content.
Goodwin advised PillPack on the deal Amazon (NASDAQ:AMZN) and PillPack today have entered into a definitive merger agreement under which Amazon will acquire PillPack. PillPack is...
You must be a Standard 1 Year member to access this content.
